Seven biological disease-modifying antirheumatic drugs (DMARDs) have been added to the immunosuppressant class of comedications on the interaction checker. The new drugs are:
- Abatacept
- Belimumab
- Certolizumab pegol
- Golimumab
- Ixekizumab
- Sarilumab
- Secukinumab
